Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-13
1995-11-07
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514410, 514411, 514428, 514456, A61K 3140
Patent
active
054648629
ABSTRACT:
Methods and pharmaceutical compositions for reducing bone loss are disclosed. 3,4-diarylchromans and their pharmaceutically acceptable salts are formulated into medicaments for the treatment of bone loss due to osteoporosis or other conditions. An exemplary 3,4-diarylchroman is centchroman (3,4-trans-2,2-dimethyl-3-phenyl-4-[p-(beta-pyrrolidinoethoxy)phenyl]-7-me thoxychroman). Formulations include tablets and other forms suitable for oral administration and controlled-release subdermal implants.
REFERENCES:
patent: 3340276 (1967-09-01), Carney et al.
patent: 3822287 (1974-07-01), Bolger et al.
patent: 4210644 (1980-07-01), Ewing et al.
patent: 4447622 (1984-05-01), Salman et al.
patent: 4489056 (1984-12-01), Himmelstein et al.
patent: 4644012 (1987-02-01), Tsuda et al.
patent: 4882347 (1989-11-01), Cozzi et al.
patent: 4902679 (1990-02-01), Benedict et al.
patent: 5015661 (1991-05-01), Walser
patent: 5063234 (1991-11-01), Bryant et al.
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5317029 (1994-05-01), Inazu et al.
Johri et al., Contraception 44(5):549-557, 1991.
Salman et al., J. Med. Chem. 26:592-595, 1983.
Ray et al., J. Med. Chem. 19(2):276-279, 1976.
Kumari et al., Contraception 13(6):665-676, 1976.
Singh et al., Chem. Abstr. 117(7):63184t, 1992.
Kamboj et al., Chem. Abstr. 88(15):99512v, 1977.
Broulik, Endocrine Regulations 25:217-219, 1991.
Liu, J. Bone Min. Res. Abstr. 5(Suppl.2):S249, 1990.
Stewart et al., Endocrinology 118:125-131, 1986.
Beall et al., Calcif. Tissue Int. 36:123-125, 1984.
Jordan et al., Breast Cancer Research and Treatment 10:31-35, 1987.
Salman et al., J. Med. Chem. 29:1801-1803, 1986.
Bain Steven D.
Labroo Virender M.
Piggott James R.
Cintins Marianne M.
Criares T. J.
Parker Gary E.
Sawislak Deborah A.
ZymoGenetics Inc.
LandOfFree
Method for inhibiting bone loss using centchroman derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting bone loss using centchroman derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting bone loss using centchroman derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-197634